Automated Fetal Cardiac Function in Babies Affected by Heart Diseases

RecruitingOBSERVATIONAL
Enrollment

495

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

January 1, 2028

Study Completion Date

February 1, 2028

Conditions
Congenital Heart DefectCardiac Function
Interventions
DIAGNOSTIC_TEST

Automated fetal cardiac function evaluation

"Evaluation of ultrasound parameters by automated algorithms.~Ultrasound assessed parameters are:~1. Pulsed wave Doppler Modified Left and Right Myocardial performance indices~2. Spatio-temporal image correlation Tricuspid, Mitral and Septal Annular Plane Systolic Excursion"

Trial Locations (7)

Unknown

RECRUITING

Royal Hospital for Women, Sydney

NOT_YET_RECRUITING

Sheba Medical Center, Tel Aviv

NOT_YET_RECRUITING

San Salvatore Hospital L'Aquila, L’Aquila

NOT_YET_RECRUITING

Vittore Buzzi Children's Hospital, Milan

NOT_YET_RECRUITING

Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste

NOT_YET_RECRUITING

Centre Hospitalier de Mayotte, Mamoudzou

NOT_YET_RECRUITING

Medical Center Ujastek, Krakow

All Listed Sponsors
collaborator

Centre Hospitalier de Mayotte

OTHER

collaborator

Vittore Buzzi Children's Hospital

OTHER

collaborator

San Salvatore Hospital of L'Aquila

OTHER

collaborator

Institute for Maternal and Child Health IRCCS Burlo Garofolo

UNKNOWN

collaborator

Sheba Medical Center

OTHER_GOV

collaborator

Clinic of Fetal Echocardiography, Medical Centre UJASTEK

UNKNOWN

lead

Anna Erenbourg

OTHER

NCT05698277 - Automated Fetal Cardiac Function in Babies Affected by Heart Diseases | Biotech Hunter | Biotech Hunter